These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse. Liu Y; Wu YP; Wada R; Neufeld EB; Mullin KA; Howard AC; Pentchev PG; Vanier MT; Suzuki K; Proia RL Hum Mol Genet; 2000 Apr; 9(7):1087-92. PubMed ID: 10767333 [TBL] [Abstract][Full Text] [Related]
23. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside. Chigorno V; Tettamanti G; Sonnino S J Biol Chem; 1996 Sep; 271(36):21738-44. PubMed ID: 8702969 [TBL] [Abstract][Full Text] [Related]
24. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C. Platt FM Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193 [TBL] [Abstract][Full Text] [Related]
25. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses. Kobayashi T; Goto I; Okada S; Orii T; Ohno K; Nakano T J Neurochem; 1992 Oct; 59(4):1452-8. PubMed ID: 1402895 [TBL] [Abstract][Full Text] [Related]
26. Mass spectrometry imaging of lipids: untargeted consensus spectra reveal spatial distributions in Niemann-Pick disease type C1. Tobias F; Olson MT; Cologna SM J Lipid Res; 2018 Dec; 59(12):2446-2455. PubMed ID: 30266834 [TBL] [Abstract][Full Text] [Related]
27. Encephaloneuropathy with lysosomal zebra bodies and GM2 ganglioside storage. Strømme P; Månsson JE; Scott H; Skullerud K; Hovig T Pediatr Neurol; 1997 Feb; 16(2):141-4. PubMed ID: 9090689 [TBL] [Abstract][Full Text] [Related]
28. Lyso-glycosphingolipids: presence and consequences. van Eijk M; Ferraz MJ; Boot RG; Aerts JMFG Essays Biochem; 2020 Sep; 64(3):565-578. PubMed ID: 32808655 [TBL] [Abstract][Full Text] [Related]
29. Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain. Dawson G; Fuller M; Helmsley KM; Hopwood JJ Neurochem Res; 2012 Jun; 37(6):1372-80. PubMed ID: 22484966 [TBL] [Abstract][Full Text] [Related]
34. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside]. Hirabayashi Y; Li YT; Li SC Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000 [No Abstract] [Full Text] [Related]
35. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Gondré-Lewis MC; McGlynn R; Walkley SU Curr Biol; 2003 Aug; 13(15):1324-9. PubMed ID: 12906793 [TBL] [Abstract][Full Text] [Related]
36. Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits. Yang DS; Stavrides P; Saito M; Kumar A; Rodriguez-Navarro JA; Pawlik M; Huo C; Walkley SU; Saito M; Cuervo AM; Nixon RA Brain; 2014 Dec; 137(Pt 12):3300-18. PubMed ID: 25270989 [TBL] [Abstract][Full Text] [Related]
37. A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis. Kim J; Byeon SK; Oglesbee D; Schultz MJ; Matern D; Pandey A Anal Bioanal Chem; 2024 Nov; 416(26):5689-5699. PubMed ID: 39190143 [TBL] [Abstract][Full Text] [Related]
38. Niemann-Pick type C disease: The atypical sphingolipidosis. Newton J; Milstien S; Spiegel S Adv Biol Regul; 2018 Dec; 70():82-88. PubMed ID: 30205942 [TBL] [Abstract][Full Text] [Related]
39. Neurobiology and cellular pathogenesis of glycolipid storage diseases. Walkley SU Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):893-904. PubMed ID: 12803923 [TBL] [Abstract][Full Text] [Related]
40. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Conzelmann E; Burg J; Stephan G; Sandhoff K Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]